Improving the online presence of Proxana Plus in a pugnacious scenario

Alfasigma, one of Italy’s major pharmaceutical players, has chosen Polk&Union to revitalize its historic product Proxana Plus, a supplement to improve prostate health.

We took on the challenge of relaunching Proxana Plus and pertaining product requirements to its HCP target, namely urologists and general practitioners, so that the Alfasigma supplement will recover its leadership in the combative and crowded market concerned, driven by its competitors’ aggressive and channeled communication.

Our response strategy was aimed at building a solid and significant digital presence for Proxana Plus activating a constant content production process and creating a new digital ecosystem that will intercept its target and reinforce awareness.

A first HCP-focused product relaunch stage

To reaffirm Proxana Plus as a leading product, Polk&Union focused on direct communication to the HCPs, in view of a more substantial campaign to be planned and launched in 2023 conducive to target expanding.

We started from the construction of a new identity and a specific storytelling that narrated the product’s strengths to the relevant audience: urologists as primary target and general practitioners as secondary target. In the next step we engaged in broadcasting all contents through targeted communication channels set up for doctors and specialists. This strategy ended with the creation of a direct lead-building engagement funnel, establishing a relationship with audiences in public mode based on content relevance as regards their needs and interests.